Front-line hormonal therapy for patients with advanced breast cancer: a community oncology research program

Autor: R V, Smalley, R B, Sigal, S, Anderson
Rok vydání: 1990
Předmět:
Zdroj: Seminars in oncology. 17(6 Suppl 9)
ISSN: 0093-7754
Popis: Megestrol acetate was administered as first-line therapy to 152 patients with advanced breast cancer. Forty-three of 136 evaluable patients (32%) obtained an objective response (95% confidence interval, 24% to 40%). Toxicity was minimal, with only 4 patients requiring dose reduction. Megestrol acetate is an effective, well-tolerated agent in previously untreated patients with advanced breast cancer.
Databáze: OpenAIRE